Omada Health announced the start of its initial public offering (IPO) roadshow, filing a registration statement with the U.S. Securities and Exchange Commission (SEC) to offer 7,900,000 shares of common stock. The company also plans to grant underwriters a 30-day option to purchase up to an additional 1,185,000 shares at the IPO price, less underwriting discounts and commissions.
The expected IPO price range is $18.00 to $20.00 per share. Omada Health intends to list its shares on the Nasdaq Global Market under the ticker symbol “OMDA.”
Morgan Stanley, Goldman Sachs & Co., and J.P. Morgan serve as lead book-running managers, with Barclays and Evercore ISI as joint book-running managers. Canaccord Genuity and Needham & Company are co-managers for the offering.
Copies of the preliminary prospectus are available through the lead managers upon request.
The registration statement has been filed with the SEC but is not yet effective; the shares cannot be sold or offers accepted until the registration becomes effective. This announcement is not an offer to sell or solicitation to buy securities in any jurisdiction where such activity would be unlawful before registration or qualification.